Tingying Zhu

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tingying Zhu. Retrieved from https://idiyas.com/inventor/tingying-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 13.1

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Shanghai, CN (2020 - 2023)
Pudong, CN (2021 - 2023)

Company Filing History:

6 out of 3,977

Novartis Ag

patents

Years Active: 2020-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12466808 - Aminopyridine derivatives and their use as selective ALK-2 inhibitors (2025-11-11),

2. 11597733 - Compounds and compositions for the treatment of parasitic diseases (2023-03-07),

3. 11590158 - Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same (2023-02-28),

4. 11135239 - Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same (2021-10-05),

5. 10947218 - Aminopyridine derivatives and their use as selective ALK-2 inhibitors (2021-03-16),

6. 10710980 - Aminopyridine derivatives and their use as selective ALK-2 inhibitors (2020-07-14),

Title: Innovator Spotlight: Tingying Zhu - Pioneering Inventor from Shanghai

Introduction: Tingying Zhu, a brilliant inventor based in Shanghai, CN, has made significant contributions to the field of pharmaceuticals with his groundbreaking innovations. Holding an impressive portfolio of 5 patents, Zhu's work exemplifies innovation in the treatment of parasitic diseases and advancements in pharmaceutical compositions.

Latest Patents:

1. Compounds and compositions for the treatment of parasitic diseases: Zhu's invention provides a compound of formula (Ia) or a pharmaceutically acceptable salt thereof, revolutionizing the treatment of parasitic diseases.

2. Pharmaceutical compositions of lipoic acid choline ester salts: Zhu's patent introduces salts of lipoic acid choline ester (LACE) and their crystalline forms, paving the way for novel methods of treatment. The pharmaceutical compositions of LACE salts presented in this patent are a significant step forward in the pharmaceutical industry.

Career Highlights: Tingying Zhu is currently affiliated with Novartis AG, a renowned pharmaceutical company known for its innovative contributions to healthcare. His association with Novartis AG underscores his commitment to pushing the boundaries of pharmaceutical research and development.

Collaborations: Zhu has had the privilege of collaborating with notable colleagues such as Liladhar Murlidhar Waykole and Luca Arista. These collaborations have enriched his work, leading to a synergistic exchange of ideas and expertise in the realm of pharmaceutical innovation.

Conclusion: In conclusion, Tingying Zhu's remarkable journey as an inventor underscores his dedication to driving progress in the pharmaceutical industry. His patents and collaborations reflect a visionary approach to solving complex medical challenges, making him a driving force in the world of innovation.

Profile summary based on public USPTO records.